Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

How to Run BPC-157 Cycle: Dosing Protocol Comparison

Conservative Systemic 250 mcg Once daily 6–8 weeks Abdominal subcutaneous Gut healing, general recovery, first-time users Lowest effective dose. Ideal for maintenance-phase healing or chronic low-grade conditions where aggressive dosing isn't justified Standar

This comparison does not assign a generated winner or score.

  • Conservative Systemic
  • 250 mcg
  • Once daily
  • 6–8 weeks
  • Abdominal subcutaneous
  • Gut healing, general recovery, first-time users
  • Lowest effective dose. Ideal for maintenance-phase healing or chronic low-grade conditions where aggressive dosing isn't justified
  • Standard Systemic
  • Twice daily (12h apart)
  • 4–6 weeks
  • Inflammatory bowel conditions, systemic inflammation
  • Gold standard for systemic protocols. Maintains stable plasma levels without trough periods
  • Localized Acute Injury
  • 250–350 mcg
  • Within 1–2 cm of injury
  • Tendon tears, ligament sprains, post-surgical soft tissue
  • Site-specific injection accelerates local repair. Justified when injury location allows safe subcutaneous access
  • Frontloaded Acute Protocol
  • 500 mcg
  • Twice daily for 10–14 days, then taper to 250 mcg twice daily
  • 6–8 weeks total
  • Injury-specific or systemic
  • Severe acute injuries, post-surgical recovery, gastric ulcers
  • Frontloading capitalizes on the inflammatory window. Taper prevents receptor desensitization as healing transitions to remodeling
  • Extended Maintenance
  • Once daily or every other day
  • 8–12 weeks
  • Chronic conditions requiring prolonged support
  • Diminishing returns after 8 weeks. Only justified for conditions with documented slow remodeling timelines (e.g., chronic tendinopathy)
More references

Related material